Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality

Yoshikatsu Miwa, Hitoshi Mitsuzumi, Takahiro Sunayama, Mika Yamada, Katsuhide Okada, Michio Kubota, Hiroto Chaen, Yasuo Mishima, Masayoshi Kibata

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

To examine the serum triglyceride (TG)-lowering effect of a soluble hesperidin derivative, glucosyl hesperidin (G-hesperidin), and its mechanisms, we carried out a G-hesperidin administration test in hypertriglyceridemic subjects. G-Hesperidin was administered to the subjects at 500 mg/d for 24 wk. In this study, the subjects were classified into high-TG type (TG > 150 mg/dL), borderline-TG type (TG 110-150 mg/dL) and normal-TG type (TG <110 mg/dL) on the basis of their initial serum TG values. Among these phenotypes, serum TG level significantly decreased in the high-TG type during the G-hesperidin administration period. It was also observed that elevated values of serum remnant-like particle cholesterol (RLP-C), apolipoprotein (apo) B, apo C-II, apo C-III and apo E occurred in the high-TG type and that these serum levels were significantly reduced by G-hesperidin administration. Moreover, polyacrylamide gel electrophoresis analysis of serum lipoproteins revealed that the very low-density lipoprotein (VLDL)/low-density lipoprotein (LDL) ratio and LDL migration index of the high-TG type were remarkably higher than those of the other phenotypes but that their high values were significantly reduced by the administration. These results indicate that G-hesperidin preferentially lowers serum TG in hypertriglyceridemic subjects and that this effect is possibly caused by the improvement of VLDL metabolic abnormality, leading to the reduction of small dense LDL.

Original languageEnglish
Pages (from-to)460-470
Number of pages11
JournalJournal of Nutritional Science and Vitaminology
Volume51
Issue number6
Publication statusPublished - Dec 2005
Externally publishedYes

Fingerprint

hesperidin
VLDL Lipoproteins
very low density lipoprotein
Triglycerides
triacylglycerols
Serum
low density lipoprotein
LDL Lipoproteins
Hesperidin
glucosyl hesperidin
apolipoprotein C-II
apolipoprotein C-III
Apolipoprotein C-II
Apolipoprotein C-III
Phenotype
phenotype
apolipoprotein E
apolipoprotein B
Apolipoproteins B
Apolipoproteins E

Keywords

  • Glucosyl hesperidin
  • Hypertriglyceridemia
  • Small dense LDL
  • Triglyceride
  • Very low-density lipoprotein

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality. / Miwa, Yoshikatsu; Mitsuzumi, Hitoshi; Sunayama, Takahiro; Yamada, Mika; Okada, Katsuhide; Kubota, Michio; Chaen, Hiroto; Mishima, Yasuo; Kibata, Masayoshi.

In: Journal of Nutritional Science and Vitaminology, Vol. 51, No. 6, 12.2005, p. 460-470.

Research output: Contribution to journalArticle

Miwa, Y, Mitsuzumi, H, Sunayama, T, Yamada, M, Okada, K, Kubota, M, Chaen, H, Mishima, Y & Kibata, M 2005, 'Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality', Journal of Nutritional Science and Vitaminology, vol. 51, no. 6, pp. 460-470.
Miwa, Yoshikatsu ; Mitsuzumi, Hitoshi ; Sunayama, Takahiro ; Yamada, Mika ; Okada, Katsuhide ; Kubota, Michio ; Chaen, Hiroto ; Mishima, Yasuo ; Kibata, Masayoshi. / Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality. In: Journal of Nutritional Science and Vitaminology. 2005 ; Vol. 51, No. 6. pp. 460-470.
@article{82a9e445dfc34f23af5b5bdb2e413c2d,
title = "Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality",
abstract = "To examine the serum triglyceride (TG)-lowering effect of a soluble hesperidin derivative, glucosyl hesperidin (G-hesperidin), and its mechanisms, we carried out a G-hesperidin administration test in hypertriglyceridemic subjects. G-Hesperidin was administered to the subjects at 500 mg/d for 24 wk. In this study, the subjects were classified into high-TG type (TG > 150 mg/dL), borderline-TG type (TG 110-150 mg/dL) and normal-TG type (TG <110 mg/dL) on the basis of their initial serum TG values. Among these phenotypes, serum TG level significantly decreased in the high-TG type during the G-hesperidin administration period. It was also observed that elevated values of serum remnant-like particle cholesterol (RLP-C), apolipoprotein (apo) B, apo C-II, apo C-III and apo E occurred in the high-TG type and that these serum levels were significantly reduced by G-hesperidin administration. Moreover, polyacrylamide gel electrophoresis analysis of serum lipoproteins revealed that the very low-density lipoprotein (VLDL)/low-density lipoprotein (LDL) ratio and LDL migration index of the high-TG type were remarkably higher than those of the other phenotypes but that their high values were significantly reduced by the administration. These results indicate that G-hesperidin preferentially lowers serum TG in hypertriglyceridemic subjects and that this effect is possibly caused by the improvement of VLDL metabolic abnormality, leading to the reduction of small dense LDL.",
keywords = "Glucosyl hesperidin, Hypertriglyceridemia, Small dense LDL, Triglyceride, Very low-density lipoprotein",
author = "Yoshikatsu Miwa and Hitoshi Mitsuzumi and Takahiro Sunayama and Mika Yamada and Katsuhide Okada and Michio Kubota and Hiroto Chaen and Yasuo Mishima and Masayoshi Kibata",
year = "2005",
month = "12",
language = "English",
volume = "51",
pages = "460--470",
journal = "Journal of Nutritional Science and Vitaminology",
issn = "0301-4800",
publisher = "Center for Academic Publications Japan",
number = "6",

}

TY - JOUR

T1 - Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality

AU - Miwa, Yoshikatsu

AU - Mitsuzumi, Hitoshi

AU - Sunayama, Takahiro

AU - Yamada, Mika

AU - Okada, Katsuhide

AU - Kubota, Michio

AU - Chaen, Hiroto

AU - Mishima, Yasuo

AU - Kibata, Masayoshi

PY - 2005/12

Y1 - 2005/12

N2 - To examine the serum triglyceride (TG)-lowering effect of a soluble hesperidin derivative, glucosyl hesperidin (G-hesperidin), and its mechanisms, we carried out a G-hesperidin administration test in hypertriglyceridemic subjects. G-Hesperidin was administered to the subjects at 500 mg/d for 24 wk. In this study, the subjects were classified into high-TG type (TG > 150 mg/dL), borderline-TG type (TG 110-150 mg/dL) and normal-TG type (TG <110 mg/dL) on the basis of their initial serum TG values. Among these phenotypes, serum TG level significantly decreased in the high-TG type during the G-hesperidin administration period. It was also observed that elevated values of serum remnant-like particle cholesterol (RLP-C), apolipoprotein (apo) B, apo C-II, apo C-III and apo E occurred in the high-TG type and that these serum levels were significantly reduced by G-hesperidin administration. Moreover, polyacrylamide gel electrophoresis analysis of serum lipoproteins revealed that the very low-density lipoprotein (VLDL)/low-density lipoprotein (LDL) ratio and LDL migration index of the high-TG type were remarkably higher than those of the other phenotypes but that their high values were significantly reduced by the administration. These results indicate that G-hesperidin preferentially lowers serum TG in hypertriglyceridemic subjects and that this effect is possibly caused by the improvement of VLDL metabolic abnormality, leading to the reduction of small dense LDL.

AB - To examine the serum triglyceride (TG)-lowering effect of a soluble hesperidin derivative, glucosyl hesperidin (G-hesperidin), and its mechanisms, we carried out a G-hesperidin administration test in hypertriglyceridemic subjects. G-Hesperidin was administered to the subjects at 500 mg/d for 24 wk. In this study, the subjects were classified into high-TG type (TG > 150 mg/dL), borderline-TG type (TG 110-150 mg/dL) and normal-TG type (TG <110 mg/dL) on the basis of their initial serum TG values. Among these phenotypes, serum TG level significantly decreased in the high-TG type during the G-hesperidin administration period. It was also observed that elevated values of serum remnant-like particle cholesterol (RLP-C), apolipoprotein (apo) B, apo C-II, apo C-III and apo E occurred in the high-TG type and that these serum levels were significantly reduced by G-hesperidin administration. Moreover, polyacrylamide gel electrophoresis analysis of serum lipoproteins revealed that the very low-density lipoprotein (VLDL)/low-density lipoprotein (LDL) ratio and LDL migration index of the high-TG type were remarkably higher than those of the other phenotypes but that their high values were significantly reduced by the administration. These results indicate that G-hesperidin preferentially lowers serum TG in hypertriglyceridemic subjects and that this effect is possibly caused by the improvement of VLDL metabolic abnormality, leading to the reduction of small dense LDL.

KW - Glucosyl hesperidin

KW - Hypertriglyceridemia

KW - Small dense LDL

KW - Triglyceride

KW - Very low-density lipoprotein

UR - http://www.scopus.com/inward/record.url?scp=31444434154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31444434154&partnerID=8YFLogxK

M3 - Article

C2 - 16521708

AN - SCOPUS:31444434154

VL - 51

SP - 460

EP - 470

JO - Journal of Nutritional Science and Vitaminology

JF - Journal of Nutritional Science and Vitaminology

SN - 0301-4800

IS - 6

ER -